Innoviva (INVA) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250.12% |
| Dec 31, 2025 | -238.25% |
| Sep 30, 2025 | 41.17% |
| Jun 30, 2025 | 236.72% |
| Mar 31, 2025 | -1,891.69% |
| Dec 31, 2024 | 114.34% |
| Sep 30, 2024 | 103.50% |
| Jun 30, 2024 | -194.94% |
| Mar 31, 2024 | 284.07% |
| Dec 31, 2023 | -124.19% |
| Sep 30, 2023 | 6,309.84% |
| Jun 30, 2023 | -96.33% |
| Mar 31, 2023 | 438.04% |
| Dec 31, 2022 | -104.50% |
| Sep 30, 2022 | 973.17% |
| Jun 30, 2022 | -43.55% |
| Mar 31, 2022 | 726.06% |
| Dec 31, 2021 | -105.89% |
| Sep 30, 2021 | -7.40% |
| Jun 30, 2021 | 1.05% |
| Mar 31, 2021 | 1,756.02% |
| Dec 31, 2020 | -115.92% |
| Sep 30, 2020 | -57.63% |
| Jun 30, 2020 | 24.41% |
| Mar 31, 2020 | 36.45% |
| Dec 31, 2019 | 22.98% |
| Sep 30, 2019 | 2.15% |
| Jun 30, 2019 | 15.10% |
| Mar 31, 2019 | -85.13% |
| Dec 31, 2018 | 436.64% |
| Sep 30, 2018 | -11.39% |
| Jun 30, 2018 | 86.67% |
| Mar 31, 2018 | -48.17% |
| Dec 31, 2017 | 146.20% |
| Sep 30, 2017 | -32.38% |
| Jun 30, 2017 | 108.64% |
| Mar 31, 2017 | -33.87% |
| Dec 31, 2016 | 69.43% |
| Sep 30, 2016 | 2.99% |
| Jun 30, 2016 | 229.13% |
| Mar 31, 2016 | 3.12% |
| Dec 31, 2015 | 193.83% |
| Sep 30, 2015 | 41.31% |
| Jun 30, 2015 | 26.78% |
| Mar 31, 2015 | 33.02% |
| Dec 31, 2014 | 25.13% |
| Sep 30, 2014 | -5.56% |
| Jun 30, 2014 | -24.53% |
| Mar 31, 2014 | -81.94% |
| Dec 31, 2013 | 5.92% |
| Sep 30, 2013 | -513.50% |
| Jun 30, 2013 | 85.66% |
| Mar 31, 2013 | 75.28% |
| Dec 31, 2012 | -25.31% |
| Sep 30, 2012 | 6.54% |
| Jun 30, 2012 | -143.88% |
| Mar 31, 2012 | 328.59% |
| Dec 31, 2011 | -20.84% |
| Sep 30, 2011 | -22.28% |
| Jun 30, 2011 | -10.49% |
| Mar 31, 2011 | -16.60% |
| Dec 31, 2010 | 8.40% |
| Sep 30, 2010 | -2.00% |